Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers

PURPOSE: Most HER2 positive invasive cancers are either intrinsic non-responsive or develop resistance when treated with 1st line HER2 targeting drugs. Both 1st and 2nd line treatments of HER2 positive cancers are aimed at targeting the HER2 receptor directly, thereby strongly limiting the treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Oncol (Dordr)
Main Authors: Hansen, Malene Bredahl, Postol, Maria, Tvingsholm, Siri, Nielsen, Inger Ødum, Dietrich, Tiina Naumanen, Puustinen, Pietri, Maeda, Kenji, Dinant, Christoffel, Strauss, Robert, Egan, David, Jäättelä, Marja, Kallunki, Tuula
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Netherlands 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090911/
https://ncbi.nlm.nih.gov/pubmed/33939112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13402-021-00603-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados